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a) In accordance with the International Health
egulations 2005 [1], all travellers arriving from
ountries or areas at risk of yellow fever (listed
elow) must present a valid yellow fever vacci-
ation certiﬁcate showing that the person was
accinated at least 10 days prior to arrival and not
ore than 10 years before arrival at the border of
he Kingdom of Saudi Arabia.
In the absence of such certiﬁcate, the individual
ill be placed under strict surveillance for 6 days
nd health ofﬁces at entry points will be responsible
or notifying the appropriate Director General of
ealth Affairs in the region or governorate about
he temporary place of residence of the visitor.
The following countries/areas are at risk of
ellow fever transmission (as deﬁned by the Inter-
ational travel and health 2012) [2]
Africa:
Angola, Benin, Burkina Faso, Burundi, Cameroon,
entral African Republic, Chad, Congo, Cote
’Ivoire, Democratic Republic of the Congo, Equa-
orial Guinea, Ethiopia, Gabon, Guinea, Guinea
issau, Gambia, Ghana, Kenya, Liberia, Mali, Mau-
itania, Niger, Nigeria, Rwanda, Senegal, Sierra
eone, Sudan, South Soudan, Togo, Uganda
South and Central America:
Argentina, Bolivarian Republic of Venezuela,razil, Colombia, Ecuador, French Guyana, Guyana,
anama, Paraguay, Peru, Plurinational State of
olivia, Suriname, Trinidad and Tobago,
 This report is being published simultaneously in both Journal
f Infection & Public Health and Journal of Epidemiology and
lobal Health.
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ttp://dx.doi.org/10.1016/j.jiph.2013.03.001(b) Aircrafts, ships and other means of trans-
ortation coming from countries affected by
ellow fever are requested to submit a certiﬁcate
ndicating that it applied disinsection in accordance
ith methods recommended by WHO.
In accordance with the International Health Reg-
lations 2005, all arriving ships will be requested to
rovide to the competent authority a valid Ship San-
tation Certiﬁcate. Ships arriving from areas at risk
or yellow fever transmission may also be required
o submit to inspection to ensure they are free of
ellow fever vectors, or disinsected, as a condition
f granting free pratique (including permission to
nter a port, to embark or disembark and to dis-
harge or load cargo or stores).
eningococcal meningitis
a) Visitors from all countries:
Visitors arriving for the purpose of Umra or
ilgrimage or for seasonal work are required to
roduce a certiﬁcate of vaccination with the
uadrivalent (ACYW135) vaccine against meningi-
is issued not more than 3 years previously and not
ess than 10 days before arrival in Saudi Arabia. The
esponsible authorities in the visitor’s country of
rigin should ensure that adults and children over
he age of 2 years are given 1 dose of the quadriva-
ent polysaccharide (ACYW135) vaccine.
(b) Visitors from African Countries
For visitors arriving from countries in thefrican meningitis belt, namely Benin, Burkina
aso, Cameroon, Chad, Central African Republic,
ôte d’Ivoire, Eritrea, Ethiopia, Gambia, Guinea,
uinea-Bissau, Mali, Niger, Nigeria, Senegal, South
for Health Sciences. Published by Elsevier Ltd. All rights reserved.
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Sudan and Sudan, in addition to the above stated
requirements, ciproﬂoxacin tablets (500mg) and
rifampin for children chemoprophylaxis will be
administered at port of entry to lower the rate of
carriers.
(c) Interior pilgrims and the Hajj workers Vac-
cination with quadrivalent (ACYW135) vaccine is
required for:
- all citizens and residents of Medina and Mecca
who have not been vaccinated during the past 3
years;
- all citizens and residents undertaking the Hajj;
- all Hajj workers who have not been vaccinated in
the past 3 years;
- any individual working at entry points or in direct
contact with pilgrims in Saudi Arabia.
Poliomyelitis
All travellers arriving from polio-endemic countries
and re-established transmission countries, namely,
Afghanistan, Chad, Nigeria and Pakistan regardless
of age and vaccination status, should receive 1 dose
of oral polio vaccine (OPV). Proof of polio vaccina-
tion at least 6 weeks prior departure is required
for visitors from polio-endemic and re-established
transmission countries to apply for entry visa for
Saudi Arabia and travellers will also receive 1 dose
of OPV at borders points on arrival in Saudi Ara-
bia. The same requirements are valid for travellers
from recently endemic countries at high risk of re-
importation of poliovirus, i.e. India.
All visitors age under 15 years travelling to Saudi
Arabia from countries reporting polio following
importation or due to circulating vaccine-derived
poliovirus in the past 12 months (as of mid-
February, 2013, see list below) should be vaccinated
against poliomyelitis with the OPV. Proof of OPV
or IPV vaccination is required 6 weeks prior the
application for entry visa. Irrespective of previous
immunization history, all visitors under 15 years
arriving in Saudi Arabia will also receive 1 dose of
OPV at border points.
Polio cases related to wild poliovirus importation
or to circulating vaccine-derived poliovirus have
been registered during the past 12 months in the
following countries: Chad, Kenya, Niger, Somalia
and Yemen.Seasonal inﬂuenza
The Ministry of Health of Saudi Arabia recommends
that international pilgrims be vaccinated against
a
p
u
WEditorial
easonal inﬂuenza before arrival into the kingdom
f Saudi Arabia, particularly those at increased
isk of severe inﬂuenza diseases including pregnant
omen, children aged <5 years, the elderly, and
ndividuals with underlying health conditions such
s HIV/AIDS, asthma, and chronic heart or lung dis-
ases.
In Saudi Arabia, seasonal inﬂuenza vacci-
ation is recommended for internal pilgrims,
articularly those at risk described above,
nd all health-care workers in the Hajj
remises.
ealth education
ealth authorities in countries of origin are
equired to provide information to pilgrims on
nfectious diseases symptoms, methods of trans-
ission, complications, and means of preven-
ion.
ood
ajj and Umrah performers are not allowed to bring
resh food in Saudi Arabia. Only properly canned or
ealed food or food stored in containers with easy
ccess for inspection is allowed in small quantities,
ufﬁcient for one person for the duration of his or
er trip.
nternational outbreaks responses
pdating immunization against vaccine-
reventable diseases in all travellers is strongly
ecommended. Preparation for international travel
rovides opportunity to review the immunization
tatus of travellers. Incompletely immunized
ravellers can be offered routine vaccina-
ions recommended in national immunization
chedules (these usually include diphtheria,
etanus, pertussis, polio, measles, and mumps),
n addition to those needed for the speciﬁc
ravel (e.g. meningococcal vaccination for
ajj).
In the event of a public health emergency of
nternational health concern, or in the case of any
isease outbreak subject to notiﬁcation under the
nternational Health Regulations 2005, the health
uthorities in Saudi Arabia will undertake additional
reventive precautions (not included in the meas-
res mentioned above) following consultation with
HO and necessary to avoid the spread of infection
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[Health conditions for travellers to Saudi Arabia fo
uring the pilgrimage or on return to their country
f origin.
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